These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6355249)

  • 21. Evaluation of cutaneous response to tetanus antigen to document immunization: preliminary observations.
    Bhatia S; Ray K; Mathur R; Yadav TP; Rai Chowdhary AN; Grover SS; Narayanan I
    Indian Pediatr; 1985 Apr; 22(4):267-73. PubMed ID: 3833747
    [No Abstract]   [Full Text] [Related]  

  • 22. [Diagnosis of delayed type hypersensitivity to Candida albicans. Evaluation of lymphocyte activation by flow cytometry (171 observations)].
    Brunet JL; Gozon G; Sainte-Laudy J; Boissel JP; Delair S; Peyramond D; Bertrand JL
    Allerg Immunol (Paris); 1997 Jun; 29(6):160-4. PubMed ID: 9254121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diphtheria-tetanus skin testing. Its clinical value for delayed hypersensitivity.
    Kaufman DB; deMendonça WC; Newton J
    Am J Dis Child; 1980 May; 134(5):479-83. PubMed ID: 7377155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Delayed cutaneous hypersensitivity testing.
    Ponte CD
    South Med J; 1982 Sep; 75(9):1076-9. PubMed ID: 6981851
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of delayed hypersensitivity: from PPD to poison ivy.
    Rosenstreich DL
    Allergy Proc; 1993; 14(6):395-400. PubMed ID: 8157162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Delayed hypersensitivity skin testing to mumps and Candida albicans antigens is normal in middle-aged HTLV-I- and-II-infected U.S. cohorts.
    Murphy EL; Wu Y; Ownby HE; Smith JW; Ruedy RK; Thomson RA; Ameti DI; Wright DJ; Nemo GJ;
    AIDS Res Hum Retroviruses; 2001 Sep; 17(13):1273-7. PubMed ID: 11559427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delayed cutaneous hypersensitivity response in patients receiving nutritional support.
    Griffin RE; Champagne CD; Bistrian BR; DiPalma SA; Blackburn GL; Benotti PN
    Clin Pharm; 1983; 2(5):432-5. PubMed ID: 6627869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of cutaneous delayed-type hypersensitivity reaction and T cell proliferative response in elderly nursing home patients: an approach to identifying immunodeficient patients.
    Castle SC; Norman DC; Perls TT; Chang MP; Yoshikawa TT; Makinodan T
    Gerontology; 1990; 36(4):217-29. PubMed ID: 2272525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Experimental murine candidiasis: cell-mediated immunity after cutaneous challenge.
    Moser SA; Domer JE; Mather FJ
    Infect Immun; 1980 Jan; 27(1):140-9. PubMed ID: 6987165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening for cell-mediated immunity in children.
    Steele RW; Suttle DE; LeMaster PC; Patterson FD; Canales L
    Am J Dis Child; 1976 Nov; 130(11):1218-21. PubMed ID: 984003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Candidin: comparison of two antigens for cutaneous delayed hypersensitivity testing.
    Fava-Netto C; Gambale W; Croce J; Paula CR; Fava Sde C
    Rev Inst Med Trop Sao Paulo; 1996; 38(6):397-9. PubMed ID: 9293084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Delayed hypersensitivity skin testing for assessing anergy in the mid-south.
    Stimpson PG; Paty JG; Hudson T; Lieberman P
    South Med J; 1976 Apr; 69(4):424-6. PubMed ID: 1265500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cell-mediated immune reponses to fungal, bacterial, viral, and chemical antigens in three nonhuman primate species.
    Eichberg JW; Kniker WT; Macias EG; Steele RW; McCullough B; Heberling RL; Kalter SS
    Dev Comp Immunol; 1980; 4(3):541-51. PubMed ID: 6250925
    [No Abstract]   [Full Text] [Related]  

  • 34. Delayed skin hypersensitivity in man. The effect of repeated tests with low-dose antigen.
    Merk K; Björkholm M; Holm G; Mellstedt H
    Acta Derm Venereol; 1988; 68(5):450-3. PubMed ID: 2461034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo and in vitro evaluation of cell-mediated immunity in patients with paracoccidiodomycosis.
    Musatti CC; Rezkallah MT; Mendes E; Mendes NF
    Cell Immunol; 1976 Jun; 24(2):365-78. PubMed ID: 779977
    [No Abstract]   [Full Text] [Related]  

  • 36. Skin reactivity to Candida and streptokinase-streptodornase antigens in normal pediatric subjects: influence of age and acute illness.
    Munoz AI; Limbert D
    J Pediatr; 1977 Oct; 91(4):565-8. PubMed ID: 333071
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Delayed-type hypersensitivity in palmoplantar pustulosis: effect of cyclosporin A treatment on skin testing with recall antigens.
    Remitz A; Lauerma AI; Erkko P; Reitamo S
    Acta Derm Venereol; 1996 Jul; 76(4):310-3. PubMed ID: 8869692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Depression of cell-mediated immunity in atopic eczema.
    McGeady SJ; Buckley RH
    J Allergy Clin Immunol; 1975 Nov; 56(5):393-406. PubMed ID: 810508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunologic responses following serial skin testing.
    Steele RW; Crabtree BL; Smith GR; Marmer DJ
    J Immunol Methods; 1986 Feb; 86(2):213-6. PubMed ID: 3944474
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pediatric case series evaluating a standardized Candida albicans skin test product.
    Ohri LK; Manley JM; Chatterjee A; Cornish NE
    Ann Pharmacother; 2004 Jun; 38(6):973-7. PubMed ID: 15084686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.